Australia markets closed

Clarus Therapeutics Holdings, Inc. (CRXT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.4200+0.0500 (+3.65%)
At close: 04:00PM EST
1.4200 0.00 (0.00%)
After hours: 06:04PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts5255
Avg. Estimate-0.68-0.86-7.9-2.39
Low estimate-1.1-1.13-18.13-3.38
High estimate-0.47-0.59-2.66-1.88
Year ago EPSN/AN/AN/A-7.9
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts5255
Avg. Estimate4.64M4.3M14.02M31.49M
Low estimate4.4M2.19M13.8M21.95M
High estimate5.2M6.4M14.6M50.2M
Year ago salesN/AN/AN/A14.02M
Sales growth (year/est)N/AN/AN/A124.60%
Earnings historyInvalid DateInvalid DateInvalid Date29/09/2021
Est. EPSN/AN/AN/A-0.81
Actual EPSN/AN/AN/A-0.26
DifferenceN/AN/AN/A0.55
Surprise %N/AN/AN/A67.90%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate-0.68-0.86-7.9-2.39
7 days ago-0.68-1.13-7.93-2.34
30 days ago-0.68-1.13-7.93-2.34
60 days ago-0.77-0.96-7.69-2.27
90 days ago-0.81-0.96-7.74-2.34
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 days1N/A1N/A
Up last 30 days1N/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesCRXTIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current yearN/AN/AN/AN/A
Next year69.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A